Repaglinide ( DrugBank: Repaglinide )

4 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1
21	ミトコンドリア病	1
46	悪性関節リウマチ	1
299	嚢胞性線維症	4

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01536366 (ClinicalTrials.gov)	June 2009	23/1/2012	Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide	Effect of BIA 9-1067 on the Pharmacokinetics of Repaglinide in Healthy Volunteers	Parkinson Disease	Drug: BIA 9-1067;Drug: Repaglinide	Bial - Portela C S.A.	NULL	Completed	18 Years	45 Years	All	27	Phase 1	Portugal

First Previous1Next Last

21. ミトコンドリア病

臨床試験数 : 39 / 薬物数 : 42 - (DrugBank : 32) / 標的遺伝子数 : 47 - 標的パスウェイ数 : 67

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04643249 (ClinicalTrials.gov)	November 10, 2020	13/11/2020	Drug-drug Interaction Study of KL1333 in Healthy Subjects	A Phase I, Open-label, Fixed-sequence, Crossover, Drug-drug Interaction Study to Investigate the Inh ...	Mitochondrial Disease	Drug: KL1333;Drug: Flurbiprofen;Drug: Dextromethorphan;Drug: Bupropion;Drug: Midazolam injection;Dru ...	Abliva AB	NULL	Completed	18 Years	65 Years	All	14	Phase 1	United Kingdom

First Previous1Next Last

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05392127 (ClinicalTrials.gov)	July 15, 2022	23/5/2022	A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healt ...	A Single-center, Open-label, Single-arm, Fixed-sequence Study to Evaluate the Pharmacokinetic Effect ...	Rheumatoid Arthritis	Drug: SHR0302 Tablets;Drug: Midazolam Maleate Tablets;Drug: Warfarin Sodium Tablets;Drug: Omeprazole ...	Jiangsu HengRui Medicine Co., Ltd.	NULL	Completed	18 Years	45 Years	Male	24	Phase 1	China

First Previous1Next Last

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00763412 (ClinicalTrials.gov)	November 2006	29/9/2008	Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis	Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis	Cystic Fibrosis Related Diabetes;Pancreatic Insufficiency	Drug: placebo;Drug: repaglinide	Arbelaez, Ana Maria	Washington University School of Medicine;National Institutes of Health (NIH);Novo Nordisk A/S;Nation ...	Completed	12 Years	24 Years	All	31	N/A	United States
2	NCT00231192 (ClinicalTrials.gov)	October 2005	3/10/2005	Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes	Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes	Diabetes	Drug: Repaglinide and Insulin	Children's Hospital of Philadelphia	NULL	Withdrawn	12 Years	20 Years	Both	0	N/A	United States
3	NCT00662714 (ClinicalTrials.gov)	September 2001	17/4/2008	Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis	Open Randomised Prospective Comparative Multi-centre Intervention Study of Patients With Cystic Fibr ...	Cystic Fibrosis;Diabetes Mellitus	Drug: Repaglinide;Drug: short-acting Insulin (Actrapid)	Mukoviszidose Institut gGmbH	Novo Nordisk A/S;Mucoviscidose-ABCF2;Assistance Publique - Hôpitaux de Paris	Completed	10 Years	N/A	Both	73	Phase 3	Austria;France;Germany;Italy
4	NCT00072904 (ClinicalTrials.gov)	June 2001	12/11/2003	Diabetes Therapy to Improve BMI and Lung Function in CF	Diabetes Therapy to Improve BMI and Lung Function in CF	Cystic Fibrosis;Diabetes Mellitus	Drug: Insulin Asparte;Drug: Repaglinide	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Cystic Fibrosis Foundation Therapeutics;Novo Nordisk A/S	Completed	16 Years	N/A	Both	108	Phase 3	United States;Canada

First Previous1Next Last

先頭へ